Moderna Therapeutics (United States)

429 papers and 16.0k indexed citations i.

About

In recent decades, authors affiliated with Moderna Therapeutics (United States) have published 429 papers, which have received a total of 16.0k indexed citations. Scholars at this organization have produced 180 papers in Infectious Diseases, 126 papers in Molecular Biology and 101 papers in Epidemiology on the topics of SARS-CoV-2 and COVID-19 Research (124 papers), Vaccine Coverage and Hesitancy (52 papers) and Viral gastroenteritis research and epidemiology (50 papers). Their work is cited by papers focused on Molecular Biology (9.3k citations), Infectious Diseases (5.2k citations) and Immunology (3.3k citations). Authors at Moderna Therapeutics (United States) collaborate with scholars in United States, United Kingdom and Canada and have published in prestigious journals including Nature, Cell and New England Journal of Medicine. Some of Moderna Therapeutics (United States)'s most productive authors include Tal Zaks, Xucheng Hou, Yizhou Dong, Róbert Langer, Örn Almarsson, Naga Kiran Duggirala, Michael J. Zaworotko, Miranda L. Perry, Giuseppe Ciaramella and Luis A. Brito.

In The Last Decade

Fields of papers published by authors at Moderna Therapeutics (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Moderna Therapeutics (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Moderna Therapeutics (United States) at the time of their publication.

Countries citing scholars working at Moderna Therapeutics (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Moderna Therapeutics (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Moderna Therapeutics (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moderna Therapeutics (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Battelle Breakdown of academic impact, for scholars at Hôpital Kirchberg Breakdown of academic impact, for scholars at Michael & Associates Breakdown of academic impact, for scholars at Cytokinetics (United States) Breakdown of academic impact, for scholars at Advanced Research Projects Agency - Energy Breakdown of academic impact, for scholars at Molecular Medicine Ireland Breakdown of academic impact, for scholars at Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni Breakdown of academic impact, for scholars at NSW Environment and Heritage